Despite 23andMe Authorization, FDA Cautious About PGx Testing
...
...
...
...
From - Diagnostic Testing & Emerging Technologies
Several recent U.S. Food and Drug Administration (FDA) actions are bringing point-of-care (POC) infectious disease tests closer to…
From - Diagnostic Testing & Emerging Technologies
Point-of-care (POC) testing that could simultaneously identify multiple sexually transmitted infections (STIs) could be a valuable addition to…